Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2002
08/13/2002US6432963 Antiinflammatory agents; tyrosine kinase inhibitor
08/13/2002US6432959 Antitumor agents
08/13/2002US6432958 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/13/2002US6432946 Psychological disorders; central nervous system disorders
08/13/2002US6432921 Oligopeptides
08/13/2002US6432879 Substituted phenyl uracils
08/13/2002CA2111447C Hypoglycemic thiazolidinediones and intermediates
08/08/2002WO2002060904A2 A process for the preparation of epothilone analogs
08/08/2002WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
08/08/2002WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes
08/08/2002WO2002060894A2 Sulfonamide lactam inhibitors of factor xa
08/08/2002WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002WO2002060450A1 Pyrimidine compounds and methods for making and using the same
08/08/2002WO2002060444A1 Muscarinic receptor agonists
08/08/2002WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
08/08/2002WO2002060374A2 Benz-1,3-azole derivatives and their uses as heparanase inhibitors
08/08/2002WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
08/08/2002WO2002010140A3 Imidazolyl derivatives
08/08/2002WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics
08/08/2002WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity
08/08/2002WO2001093840A3 Ligands of integrin receptors
08/08/2002WO2001092991A3 Design of polyketide synthase genes
08/08/2002WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
08/08/2002WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
08/08/2002US20020107402 Aminoaryl oxazolidinone N-oxides
08/08/2002US20020107398 Microbicides in crop protection
08/08/2002US20020107392 Quinolinone derivatives
08/08/2002US20020107290 Inhibiting activated blood-coagulation factor X
08/08/2002US20020107274 Potent inhibitors of cyclin dependent kinases; treating cancer or other proliferative diseases
08/08/2002US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups
08/08/2002US20020107252 Novel Compounds
08/08/2002US20020106762 Generating preerential compound for use as prophylactic agent; obtain chemical intermediate, incubate with enzyme, recover prophylactic agent
08/08/2002CA2672805A1 Pyrimidine derivatives
08/08/2002CA2436774A1 Sulfonamide lactam inhibitors of factor xa
08/08/2002CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
08/08/2002CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
08/08/2002CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes
08/08/2002CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
08/08/2002CA2435958A1 Pyrimidine compounds and methods for making and using the same
08/08/2002CA2434839A1 Muscarinic receptors agonists
08/07/2002EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
08/07/2002EP1228367A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
08/07/2002EP1228087A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions
08/07/2002EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity
08/07/2002EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
08/07/2002EP1228062A1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridines
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
08/07/2002EP1228051A1 Semicarbazone derivatives and their use as thrombopoietin mimetics
08/07/2002EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors
08/07/2002EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
08/07/2002EP1077976B1 Water soluble azoles as broad-spectrum antifungals
08/07/2002EP1058679A4 Synthesis of epothilones, intermediates thereto and analogues therof
08/07/2002CN1362955A C7 ester substituted taxanes as antitumor agents
08/07/2002CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor
08/07/2002CN1362953A Pyrazole compositions useful as inhibitors of ERK
08/07/2002CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/07/2002CN1088757C Process for preapring thiols
08/07/2002CN1088709C Amine compound and its acid addition salt
08/07/2002CN1088707C 2-carbonylthiazole derivatives and use of the same
08/07/2002CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments
08/07/2002CN1088587C Topical anti-inflammatory compositions containing piroxican
08/06/2002US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors
08/06/2002US6429206 Using agonist of nicotinergic acetylcholine receptors
08/06/2002US6428667 Multichromophore fluorescent probes using DNA intercalation complexes
08/06/2002CA2223237C 1-phenyl-pyrazole derivatives and their use as parasiticidal agents
08/01/2002WO2002059121A1 Monomer for use in preparation of a polymer to be used in optical devices
08/01/2002WO2002059120A1 Process for the preparation of isothiazole derivatives
08/01/2002WO2002059119A1 Acylation of amino-isothiazoles using trialky-aluminium agents
08/01/2002WO2002059118A1 Process for n-(oxyalkylation) of carboxamides
08/01/2002WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/01/2002WO2002059115A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents
08/01/2002WO2002059114A1 Lfa-1 antagonist compounds
08/01/2002WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059108A1 Melanocortin receptor agonists
08/01/2002WO2002059100A1 Halogen compounds having thrombopoietin receptor agonism
08/01/2002WO2002059099A1 Cyclic compounds having thrombopoietin receptor agonism
08/01/2002WO2002059098A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
08/01/2002WO2002059096A1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
08/01/2002WO2002059095A1 Melanocortin receptor agonists
08/01/2002WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2002010160A3 Substituted heterocyclyl alkylamino-1,3,5-triazines
08/01/2002WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors
08/01/2002US20020103387 Compounds which mimic the chemical and biological properties of discodermolide
08/01/2002US20020103384 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
08/01/2002US20020103247 Indole and dihydroindole derivatives
08/01/2002US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto